Clinical Trial Update: Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PLN-74809 in acute respiratory distress syndrome (ARDS) associated with severe COVID-19; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• PLN-74809

Snippet

Sponsor: Pliant Therapeutics, Inc. | Conditions: Acute Respiratory Distress Syndrome, SARS-CoV-2 | Phase 2 | Status: TERMINATED | Results posted: 2022-11-17